Literature DB >> 6893377

Psoriasis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893377      PMCID: PMC1272264     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  11 in total

1.  HLA C and D antigens associated with psoriasis.

Authors:  A J McMichael; V Morhenn; R Payne; T Sasazuki; E M Farber
Journal:  Br J Dermatol       Date:  1978-03       Impact factor: 9.302

2.  Topical steroid depression of the hypothalamic-pituitary-adrenal axis in psoriasis vulgaris.

Authors:  I N Rabinowitz; W Watson; E M Farber
Journal:  Dermatologica       Date:  1977

3.  Polyamines and psoriasis.

Authors:  J J Voorhees
Journal:  Arch Dermatol       Date:  1979-08

Review 4.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

5.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.

Authors:  J A Parrish; T B Fitzpatrick; L Tanenbaum; M A Pathak
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

6.  Retinoids in dermatology: an interim report.

Authors:  G L Peck
Journal:  Arch Dermatol       Date:  1980-03

Review 7.  Methotrexate.

Authors:  G D Weinstein
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

8.  HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies.

Authors:  A Svejgaard; L S Nielsen; E Svejgaard; F K Nielsen; A Hjortshoj; H Zachariae
Journal:  Br J Dermatol       Date:  1974-08       Impact factor: 9.302

9.  Epidermal cyclic AMP is not decreased in psoriasis lesions.

Authors:  K Adachi; H Iizuka; K M Halprin; V Levine
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

10.  Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.

Authors:  R S Stern; L A Thibodeau; R A Kleinerman; J A Parrish; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.